Physician

Paul Hahn, MD

According to 2025 Medicare claims, Paul Hahn, MD (NPI: 1043360704) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is ASSOCIATED RETINAL CONSULTANTS LLC (NPI: 1164578894; TIN: 208346981) and primary practice location at 07470-6631. Hahn is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Hahn's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 972 traditional Medicare patients, billed 32,119 HCPCS/CPT codes, and received $3,735,018 in Medicare payments. The top billing code was J0177 (Injection, aflibercept hd, 1 mg). Part D data shows 307 prescription claims across 88 beneficiaries totaling $32,161 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 154 records totaling $222,519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $514,569 to $3,735,018. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $7,032 and ending at $32,161. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	430	2,803	$514,569
2016	1,402	11,423	$1,509,280
2017	1,722	20,139	$2,880,496
2018	1,736	22,159	$3,419,272
2019	1,140	16,347	$2,553,405
2020	1,110	13,798	$2,703,016
2021	1,044	15,306	$2,970,983
2022	1,009	17,678	$3,092,858
2023	1,075	25,943	$3,208,401
2024	972	32,119	$3,735,018

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	35	127	$7,032
2016	118	319	$18,362
2017	185	518	$41,744
2018	201	742	$62,616
2019	138	507	$50,094
2020	105	402	$60,167
2021	124	426	$49,876
2022	111	363	$44,647
2023	103	322	$27,896
2024	88	307	$32,161

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0177	Injection, aflibercept hd, 1 mg	149	4,760	$263
67028	Injection of drug into eye	337	1,715	$105
92014	Established patient complete exam of visual system	869	2,569	$104
92134	Imaging of retina	887	2,595	$36
92202	Extended exam of the back part of the eye with optic nerve drawing	774	2,034	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolensa	Bromfenac Sodium	22	747	$7,680
Prednisolone Acetate	Prednisolone Acetate	116	4,273	$4,811
Loteprednol Etabonate	Loteprednol Etabonate	15	940	$2,727
Bromfenac Sodium	Bromfenac Sodium	14	381	$2,005
Ofloxacin	Ofloxacin	38	761	$418

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	70	$50,570	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	84	$171,949	Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Paul Hahn, MD?

Tedicare shows public-source Medicare data for Paul Hahn, MD (NPI 1043360704), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Paul Hahn, MD have ACO affiliation data?

Paul Hahn, MD is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Paul Hahn, MD?

Paul Hahn, MD is linked to ASSOCIATED RETINAL CONSULTANTS LLC (billing NPI 1164578894) in the available physician profile data.

Does Paul Hahn, MD have Open Payments data?

Paul Hahn, MD has 154 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.